ENTITY

Myriad Genetics (MYGN US)

10
Analysis
Health CareUnited States
Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.
more
Company Presentation04 Nov 2025 05:30
Company Presentation06 Aug 2025 04:30
Company Presentation07 May 2025 04:30
Company Presentation25 Feb 2025 05:30
Company Presentation08 Nov 2024 05:30
x